Related Experiment Video
Updated: May 28, 2026

Telomere Length and Telomerase Activity; A Yin and Yang of Cell Senescence
Published on: May 22, 2013
Telomere length dynamics do not predict subclinical atherosclerosis progression over a six-year period
Vicente Andrés1,2, Juan M Fernández-Alvira3, Beatriz Dorado3,4
1Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, Madrid, 28029, Spain. vandres@cnic.es.
Insights
Changes in leukocyte telomere length (LTL) do not predict subclinical atherosclerosis (SA) progression in healthy middle-aged adults. This longitudinal study found no significant association between LTL dynamics and SA progression over six years.
Area of Science:
- Cardiovascular Disease Research
- Biomarker Discovery
- Aging and Longevity Studies
Background:
- Subclinical atherosclerosis (SA) progression is linked to mortality, necessitating reliable biomarkers.
- Leukocyte telomere length (LTL) attrition is associated with cardiovascular disease, but its predictive value for SA progression is unclear.
Purpose of the Study:
- To investigate whether accelerated LTL attrition predicts SA progression over a 6-year period.
- To evaluate LTL dynamics as a potential early biomarker for subclinical atherosclerosis progression in healthy middle-aged individuals.
Main Methods:
- Longitudinal study of 1068 healthy middle-aged participants from the Progression of Early Subclinical Atherosclerosis (PESA) study.
- Leukocyte telomere length (LTL) measured using high-throughput quantitative fluorescence in-situ hybridization at baseline and after 6 years.
- Subclinical atherosclerosis (SA) assessed via 3D vascular ultrasound of carotid and femoral arteries; statistical analyses employed linear and logistic regression.
Main Results:
- No significant association was found between changes in LTL and changes in plaque volume over 6 years.
- LTL dynamics did not predict the odds of SA progression over the 6-year study period.
- Analysis of short telomere load changes yielded similar null results.
Conclusions:
- Leukocyte telomere length (LTL) dynamics demonstrate limited utility as an early predictive biomarker for subclinical atherosclerosis (SA) progression.
- Further research may be needed to identify reliable and cost-effective biomarkers for monitoring SA progression.
Abstract:
Subclinical atherosclerosis (SA) burden and progression are independently associated with all-cause mortality. However, monitoring SA progression requires reliable and cost-effective biomarkers. While leukocyte telomere length (LTL) attrition has been linked to cardiovascular disease and mortality, it remains uncertain whether changes in LTL over time can predict SA progression. In this study, we conducted a longitudinal study to assess whether accelerated LTL attrition is associated with SA progression over a 6-year period in healthy middle-aged individuals. LTL was measured by high-throughput quantitative fluorescence in-situ hybridization in peripheral-blood leukocyte samples obtained 6 years apart from a sub-cohort of 1068 Progression of Early Subclinical Atherosclerosis (PESA)-study participants. SA was assessed by 3D vascular ultrasound in the carotid and femoral territories. Associations were evaluated using linear and logistic regression models. LTL parameters at baseline and after 6 years showed a positive correlation, but no significant associations were found between changes in LTL and changes in plaque volume over 6 years, either in the total sample or when stratified by sex. Likewise, no significant associations were found between LTL changes and the odds of SA progression over a 6-year period. Similar results were found when considering short telomere load changes. These findings suggest limited utility of LTL dynamics as an early biomarker for SA progression in healthy middle-aged individuals.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
Longitudinal Research
Replicative Cell Senescence
Replication in Eukaryotes
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Replication in Eukaryotes
